- VRTX +0.82%
Vertex Pharmaceuticals Incorporated (VRTX): Why Do Hedge Funds Recommend This Biotech Stock?
Yahoo Finance · 5 days ago
Search results
Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases.
- 478.65Add to watchlist+3.91 (+0.82%)At close:4:00 PM EDTThu. Sep 12, 2024485.00 +6.35 (+1.33%)After hrs:4:44 PM EDTThu. Sep 12, 2024Nasdaq Real Time Price (USD) · Market closed
- Open474.74High479.51Low468.46
- Mkt Cap123.54BP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close474.7452 Wk. Low341.8552 Wk. High510.64
What analysts are sayingTop storiesRelated stocks
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in South Boston, Massachusetts, and three research facilities, in San Diego ...
Vertex Pharmaceuticals strikes at the core of serious diseases to change people's lives – learn about our mission, values and recognition.
Vertex Pharmaceuticals is focused on discovering, developing and producing innovative medicines so people with serious diseases can lead better lives.
For a company founded more than 30 years ago, Vertex Pharmaceuticals—in its current iteration—came into being after a prescient R&D strategy decision from its top brass about a decade ago.
Aug 10, 2014 · Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and...
